Overview
My primary research focus lies at the intersection of kidney and cardiovascular disease including pulmonary hypertension, heart failure, and atherosclerotic disease in patients with chronic kidney disease.
Current Appointments & Affiliations
Assistant Professor of Medicine
·
2021 - Present
Medicine, Nephrology,
Medicine
Member in the Duke Clinical Research Institute
·
2019 - Present
Duke Clinical Research Institute,
Institutes and Centers
Recent Publications
Trends in Steroidal Mineralocorticoid Receptor Antagonist Prescriptions by Nephrologists after Approval of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone for CKD.
Journal Article J Am Soc Nephrol · August 18, 2025 Full text Link to item CiteHigher versus Lower Phosphate Targets for Patients Undergoing In-Center Hemodialysis: A Randomized Controlled Trial.
Journal Article J Am Soc Nephrol · July 10, 2025 Full text Link to item CiteGlucarpidase for treatment of high-dose methotrexate toxicity.
Journal Article Blood · April 24, 2025 High-dose methotrexate (MTX) results in high rates of acute kidney injury (AKI), neutropenia, and hepatotoxicity. Glucarpidase is a recombinant enzyme that cleaves MTX, but clinical data supporting its use are scarce. We examined the association between gl ... Full text Link to item CiteRecent Grants
TRIO NRSA Training Core-Post Doc Trainee
Inst. Training Prgm or CMEMentor · Awarded by University of North Carolina - Chapel Hill · 2023 - 2028Novel Mechanisms and Therapeutic Targets for Pulmonary Hypertension in End-Stage Renal Disease (K23)
ResearchPrincipal Investigator · Awarded by National Heart, Lung, and Blood Institute · 2021 - 2026The Role of Klotho and Serotonin in Cardiovascular Outcomes and Mortality in CKD
ResearchCo-Principal Investigator · Awarded by University of Pennsylvania · 2021 - 2024View All Grants
Education, Training & Certifications
Mercer University, School of Medicine ·
2013
M.D.